Synergism between dexketoprofen and meloxicam in an orofacial formalin test was not modified by opioid antagonists

Pharmacological Reports

Volumn 63, Issue 2, 2011, Pages 433-440

  Gonzalez, Claudia ^a   Zegpi, Carlos ^a   Noriega, Viviana ^b   Prieto, Juan C ^a,c   Miranda, Hugo F ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

^c HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Algesiometric tests; Antinociception; Isobolographic analysis; Synergism

Indexed keywords

DEXKETOPROFEN; FORMALDEHYDE; MELOXICAM; NALTREXONE; NALTRINDOLE; NORBINALTORPHIMINE;

ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENCY; DRUG POTENTIATION; DRUG RESPONSE; ENANTIOMER; FACE PAIN; MALE; MOUSE; NONHUMAN;

EID: 79955928753     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70509-6     Document Type: Article

References (31)

1. Abul-Husn NS, Sutak M, Milne B, Jhamandas K: Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of μ- and -opioid receptor antagonists. Br J Pharmacol, 2007, 151, 877-887. (Pubitemid 47075317)
2. Barrera NP, Morales B, Torres S, Villalón M: Principles: Mechanisms and modeling of synergism in cellular responses. Trends Pharmacol Sci, 2005, 26, 526-532. (Pubitemid 41338563)
3. Broadbear JH, Negus SS, Butelman ER, De Costa BR, Woods JH: Differential effects of systemically administered nor-binaltorphimine (Nor-BNI) on kappa-opioid antagonists in the mouse writhing assay. Psychopharmacology (Berl), 1991, 115, 311-319. (Pubitemid 24217089)
4. Capone ML, Tacconelli S, Di Francesco L, Sacchetti A, Sciulli MG, Patrignani P: Pharmacodynamic of cyclooxygenase inhibitors in humans. Prostaglandins Other Lipid Mediat, 2007, 82, 85-94. (Pubitemid 44895440)
5. Choi SS, Han KJ, Lee HK, Han EJ, Suh HW: Possible antinociceptive mechanisms of opioid receptor antagonists in the mouse formalin test. Pharmacol Biochem Behav, 2003, 75, 447-457.
6. Chou TC: Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev, 2006, 58, 621-681.
7. Crain SM, Shen KF: Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low dose naltrexone, unmasking potent opioid analgesia. Brain Res, 2001, 88, 75-82. (Pubitemid 32056264)
8. Endoh HT, Matsuura H, Tanaka C, Nagase H: Norbinaltorphimine: a potent and selective κ-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther, 1992, 316, 30-42.
9. Goldstein A, Aronow L, Kalman SM: Principles of drug action. 2nd edn., J. Wiley & Sons, Inc., New York, 1974, 89-96.
10. Hilário MOE, Terreri MT, Len CA: Nonsteroidal antiinflammatory drugs: cyclooxygenase 2 inhibitors. J Pediatr (Rio J), 2006, 82, 206-212.
11. Ito S, Okuda-Ashitaka E, Minami T: Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci Res, 2001, 41, 299-332. (Pubitemid 33733750)
12. Jackson ID, Heidemann BH, Wilson J, Power L, Brown RD: Double-blind, randomized, placebo-controlled trial comparing rofecoxib with dexketoprofen trometamol in surgical dentistry. Br J Anaesth, 2004, 92, 675-680. (Pubitemid 38578755)
13. Luccarini P, Childeric A, Gaydier AM, Voisin D, Dallel R: The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. J Pain, 2006, 7, 908-914. (Pubitemid 44854734)
14. Malan TP Jr, Marsh G, Hakki SI, Grossman E, Traylor L, Hubbard RC: Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty. Anesthesiology, 2003, 98, 950-956. (Pubitemid 36373231)
15. Mauleón D, Artigas R, García ML, Carganico G: 1996. Preclinical and clinical development of dexketoprofen. Drugs, 1996, 52, Suppl 5, 24-46. (Pubitemid 26379063)
16. Miranda HF, Pinardi G: Lack of effect of naltrindole on the spinal synergism between morphine and nonsteroidal anti-inflammatory drugs (NSAIDs). J Physiol Pharmacol, 2009, 60, 71-76.
17. Miranda HF, Pinardi G: Lack of effect of naltrexone on the spinal synergism between morphine and non steroidal anti-inflammatory drugs. Pharmacol Rep, 2009, 61, 268-274.
18. Miranda HF, Puig MM, Dursteler C, Prieto JC, Pinardi G: Dexketoprofen-induced antinociception in animal models of acute pain: Synergy with morphine and paracetamol. Neuropharmacology, 2007, 52, 291-296 (Pubitemid 46137971)
19. Miranda HF, Sierralta F, Prieto JC: Synergism between NSAIDs in the orofacial formalin test in mice. Pharmacol Biochem Behav, 2009, 92, 314-318
20. Satyanarayana PSV, Jain NK, Singh A, Kulkarni SK: Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice. Prog Neuropsychopharmacol Biol Psychiatry, 2004, 28, 641-649. (Pubitemid 38987389)
21. Schug SA, Monapas A: Update on the role of nonopioids for postoperative pain treatment. Best Pract Res Clin Anaesthesiol, 2007, 2, 15-30. (Pubitemid 46478025)
22. Shen KF, Crain SM: Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Brain Res, 1997, 757, 176-190.
23. Suleyman H, Demircan B, Karagoz Y: Antiinflammatory and side effects of cyclooxygenase inhibitors. Pharmacol Rep, 2007, 59, 247-258. (Pubitemid 47299726)
24. Suzuki T, Narita M, Takahashi Y, Misawa M, Nagase H: Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine. Eur J Pharmacol, 1992, 213, 91-97.
25. Tallarida RJ: Drug synergism and dose-effect data analysis, Chapman & Hall CRC Press, Boca Raton, FL, 2000, 1-69.
26. Takemori AE, Ho BY, Naeseth JS, Portoghese PS: Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther, 1988, 246, 255-258.
27. Takemura M, Sugijo S, Moritami M, Kobayashi M, Yomehara N: Mechanisms of orofacial pain control in the central nervous system. Arch Histol Cytol, 2006, 69, 79-100.
28. Waldhoer M, Bartlett SE, Whistler JL: Opioid receptors. Annu Rev Biochem, 2004, 73, 953-990. (Pubitemid 39050391)
29. Wettstein JG, Grouhel A: Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay. Pharmacol Biochem Behav, 1996, 53, 411-416. (Pubitemid 26060773)
30. - co-transporter 2 in mouse medullary dorsal horn contributes to the formalininduced inflammatory orofacial pain. Neurosci Lett, 2009, 457, 36-40.
31. Zegpi C, González C, Pinardi G, Miranda HF: The effect of opioid antagonists on synergism between dexketoprofen and tramadol. Pharmacol Res, 2009, 60, 291-295.